Nemaura Medical Inc. (NMRD)

Nemaura Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Revenue	-1.55	0.08	0.5	0	0	0
Revenue Growth (YoY)	-	-84.71%	-	-	-	-
Cost of Revenue	3.03	1.55	0.34	0	0	0
Gross Profit	-4.58	-1.48	0.16	0	0	0
Selling, General & Admin	5.59	5.6	6.17	3.03	2.77	2.18
Research & Development	1.89	1.54	1.56	1.55	2.01	2.3
Other Operating Expenses	0.98	0.98	0	0	0	0
Operating Expenses	7.48	7.14	7.73	4.59	4.78	4.48
Operating Income	-9.71	-9.6	-7.57	-4.59	-4.78	-4.48
Interest Income	2.92	6.41	6.67	2.01	0	0.02
Interest Expense	5.67	6.41	6.67	2.01	0	0
Other Expense / Income	-5.22	4.55	6.67	2.01	-	-0.02
Pretax Income	-10.65	-14.14	-14.24	-6.59	-4.77	-4.45
Income Tax	-0.95	10.96	-0.35	-0.34	-0.61	0.02
Net Income	-6.3	-25.1	-13.89	-6.26	-4.16	-4.45
Shares Outstanding (Basic)	29	25	23	22	21	18
Shares Outstanding (Diluted)	29	25	23	22	21	18
Shares Change	19.90%	6.39%	4.94%	7.10%	15.01%	-87.95%
EPS (Basic)	-0.22	-1.01	-0.59	-0.28	-0.20	-0.25
EPS (Diluted)	-0.22	-1.01	-0.59	-0.28	-0.20	-0.25
Free Cash Flow	-9.74	-8.99	-7.46	-6.83	-3.66	-3.64
Free Cash Flow Per Share	-0.34	-0.36	-0.32	-0.31	-0.18	-0.20
Gross Margin	-	-1916.30%	31.67%	-	-	-
Operating Margin	-	-12454.23%	-1502.35%	-	-	-
Profit Margin	-	-32584.93%	-2755.83%	-	-	-
Free Cash Flow Margin	-	-11669.95%	-1480.54%	-	-	-
EBITDA	-7.59	-8.17	-7.34	-4.49	-4.72	-4.44
EBITDA Margin	-	-10605.65%	-1456.74%	-	-	-
Depreciation & Amortization	0.49	0.44	0.23	0.1	0.05	0.03
EBIT	-8.07	-8.62	-7.57	-4.59	-4.78	-4.48
EBIT Margin	-	-11182.18%	-1502.35%	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.